Advert - Advanced Accelerator Applications – Case AUTH/3528/6/21
-
Date posted21 June 2022
-
SanctionAdvertisement,
-
Case number/s
For promoting an unlicensed medicine (177Lu-PSMA-617) prior to the grant of the marketing authorisation, Advanced Accelerator Applications (a Novartis company) was ruled in breach of the following clauses of the 2019 Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 3.1 - Promoting an unlicensed medicine
Clause 9.1 - Failing to maintain high standards